#PracticeChaning

Paper: Lack of Benefit of Autologous Hematopoietic Cell Transplantation (auto-HCT) in Mantle Cell Lymphoma (MCL) Patients (pts) in First Complete Remission (CR) with Undetectable Minimal Residual Dise...

Much awaited ECOG 4151 results out. IMO definitely ends debate for autoHCT in MCL in MRD negative CR1. #PracticeChaning and congrats to my friend @timfenske in advancing patient care @MCWCancerCenter @ASH_hematology #ASH2025
ash.confex.com/ash/2024/web...